About shanghai fosun pharmaceutical group - SFOSF
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.
SFOSF At a Glance
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Building A
Shanghai, Shanghai 200233
| Phone | 86-21-3398-7870 | Revenue | 5.66B | |
| Industry | Pharmaceuticals: Major | Net Income | 384.88M | |
| Sector | Health Technology | Employees | 40,557 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
SFOSF Valuation
| P/E Current | 13.395 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 12.614 |
| Price to Sales Ratio | 0.857 |
| Price to Book Ratio | 0.746 |
| Price to Cash Flow Ratio | 6.277 |
| Enterprise Value to EBITDA | 11.713 |
| Enterprise Value to Sales | 1.661 |
| Total Debt to Enterprise Value | 0.534 |
SFOSF Efficiency
| Revenue/Employee | 139,622.339 |
| Income Per Employee | 9,489.77 |
| Receivables Turnover | 4.085 |
| Total Asset Turnover | 0.351 |
SFOSF Liquidity
| Current Ratio | 0.921 |
| Quick Ratio | 0.727 |
| Cash Ratio | 0.43 |
SFOSF Profitability
| Gross Margin | 43.903 |
| Operating Margin | 6.398 |
| Pretax Margin | 6.197 |
| Net Margin | 6.797 |
| Return on Assets | 2.389 |
| Return on Equity | 5.96 |
| Return on Total Capital | 3.348 |
| Return on Invested Capital | 4.558 |
SFOSF Capital Structure
| Total Debt to Total Equity | 77.567 |
| Total Debt to Total Capital | 43.683 |
| Total Debt to Total Assets | 31.103 |
| Long-Term Debt to Equity | 27.476 |
| Long-Term Debt to Total Capital | 15.474 |